TECH
BIO-TECHNE Corp
BIO-TECHNE Corp (TECH) has 9 SEC Form 4 filings (18 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jun 4, 2026.
Insiders have net sold $320K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Kim Kelderman
- Employees:3,100
- HQ:Minneapolis, MN, US
- IPO:1989-02-09
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$320K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$11.2B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Herr Amy E.First filing | Director | Sale | 6,636 | $320K | May 12 | SEC ↗ |
Congress trading TECH
See timeline →- DRep. April DelaneySale$1,001 - $15,0002026-04-08
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Related companies
BIO-TECHNE Corp is in the Healthcare sector.